Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
Mark C ZobeckMelanie Brooke BernhardtKala Y KamdarKaren R RabinPhilip J LupoMichael E ScheurerPublished in: Pharmacotherapy (2023)
These predictors of MTX toxicities may allow for more precise individualized toxicity risk prediction.